Liver fibrosis indices associated with substantial hematoma expansion in Chinese patients with primary intracerebral hemorrhage.
Liver fibrosis indices associated with substantial hematoma expansion in Chinese patients with primary intracerebral hemorrhage.
复制标题
中国原发性脑出血患者肝纤维化指数与血肿严重扩张相关
DOI:
10.1186/s12883-021-02494-0
复制
发表时间:
2021-12-09
期刊:
影响因子:
2.6
通讯作者:
Wang D
中科院分区:
文献类型:
--
作者:
Wang H;Wu J;Yang X;Liu J;Tao W;Hao Z;Wu B;Liu M;Zhang S;Wang D
Whether liver fibrosis is associated with increased risk for substantial hematoma expansion (HE) after intracerebral hemorrhage (ICH) is still uncertain. We evaluated the association between various liver fibrosis indices and substantial HE in a Chinese population with primary ICH. Primary ICH patients admitted to West China Hospital within 24 h of onset between January 2015 and June 2018 were consecutively enrolled. Six liver fibrosis indices were calculated, including aspartate aminotransferase (AST)-platelet ratio index (APRI), AST/alanine aminotransferase ratio-platelet ratio index (AARPRI), fibrosis-4 (FIB-4), modified fibrosis-4 (mFIB-4), fibrosis quotient (FibroQ) and Forns index. Substantial HE was defined as an increase of more than 33% or 6 mL from baseline ICH volume. The association of each fibrosis index with substantial HE was analyzed using binary logistic regression. Of 436 patients enrolled, about 85% showed largely normal results on standard hepatic assays and coagulation parameters. Substantial HE occurred in 115 (26.4%) patients. After adjustment, AARPRI (OR 1.26, 95% CI 1.00-1.57) and FIB-4 (OR 1.15, 95% CI 1.02-1.30) were independently associated with substantial HE in ICH patients within 24 h of onset, respectively. In ICH patients within 6 h of onset, each of the following indices was independently associated with substantial HE: APRI (OR 2.64, 95% CI 1.30-5,36), AARPRI (OR 1.55, 95% CI 1.09-2.21), FIB-4 (OR 1.35, 95% CI 1.08-1.68), mFIB-4 (OR 1.09, 95% CI 1.01-1.18), FibroQ (OR 1.08, 95% CI 1.00-1.16) and Forns index (OR 1.37, 95% CI 1.10-1.69). Liver fibrosis indices are independently associated with higher risk of substantial HE in Chinese patients with primary ICH, which suggesting that subclinical liver fibrosis could be routinely assessed in such patients to identify those at high risk of substantial HE. The online version contains supplementary material available at 10.1186/s12883-021-02494-0.
登录
查看更多内容
影响因子:
2.5
作者:
Nallagangula KS;Nagaraj SK;Venkataswamy L;Chandrappa M
通讯作者:
Chandrappa M
影响因子:
2.9
作者:
Baik, Minyoul;Kim, Seung Up;Kim, Young Dae
通讯作者:
Kim, Young Dae
影响因子:
158.5
作者:
Mayer, Stephan A.;Brun, Nikolai C.;Steiner, Thorsten
通讯作者:
Steiner, Thorsten
影响因子:
5.3
作者:
Kim, Seung Up;Song, Dongbeom;Kim, Young Dae
通讯作者:
Kim, Young Dae
DOI:
10.3390/diagnostics11010098
发表时间:
2021-01-09
期刊:
Diagnostics (Basel, Switzerland)
影响因子:
--
作者:
Ballestri S;Mantovani A;Baldelli E;Lugari S;Maurantonio M;Nascimbeni F;Marrazzo A;Romagnoli D;Targher G;Lonardo A
通讯作者:
Lonardo A